But GlaxoSmithKline CEO Jean-Pierre Garnier has taken a "trust me" approach to new drugs he's been buying, promising to show them all off later this year.
Each new story appeared against a constant background of complaints about bosses being paid far too much not least GlaxoSmithKline's Jean-Pierre Garnier, who this week belatedly, and grudgingly, accepted a restructured pay package that would not reward him so well in the event of failure.